Correlation of Clinicoserologic and Pathologic Classifications of Inflammatory Myopathies
Medicine 92:15-24, Fernandez, C.,et al, 2013
Clinicopathologic Conference, Thymoma with Paraneoplastic Myasthenia Gravis, Polymyositis and Myocarditis, and Brain Stem Encephalitis
NEJM 365:2413-2422, Case 39-2011, 2011
Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999
Immunologic Aspects of Neurological and Neuromuscular Diseases
JAMA 268:2918-2922, Zweiman,B.&Levinson,A.I., 1992
Polymyositis & Dermatomyositis
NEJM 292:344, 1975, 292:403975., Bohan,A.,et al, 1975
The Incidence of the Non-Metastatic Neurological Syndromes of Obscure Origin in the Reticuloses
Brain 93:629, Currie,S.,et al, 1970
Diseases of Muscles-Clinical Manifestations & Differential Diagnosis
The New Physic 263, 1967, Oct., Boshes,L., 1967
The Remote Effects of Cancer on the Nervous System
Proc Roy Soc Med 60:683, Wilkinson,M., 1967
Current Concepts in the Idiopathic Inflammatory Myopathies:Polymyositis, Dermatomyositis, and Related Disorders
Ann Int Med 111:143-157, Plotz,P.H.,et al, 1989
Inflammatory Myopathies
Ann Neurol 17:215-227, 317-3231985., Mastaglia,F.L.,et al, 1985
Inflammatory Myopathies with Anti-Ku Antibodies
Medicine 91:95-102, Rigolet,A.,et al, 2012
Sjogren Syndrome: Neurologic Complications
www.Medlink.com,Jan, Roman,G.C., 2010
Polymyositis and Dermatomyositis
Lancet 362:971-982, Dalakas,M.C.&Hohlfeld,R., 2003
Treatment of Inflammatory Myopathies
Muscle & Nerve 20:651-664997., Mastaglia,F.L.,et al, 1997
Intravenous Immunoglobulin Treatment of Neurological Disease
JNNP 60:359-361, Otten,A.,et al, 1996
Acute Neuromuscular Respiratory Paralysis
JNNP 56:334-343, Hughes,R.A.C.&Bihari,D., 1993
Efficacy of Intravenous Gammaglobulin Therapy in Chronic Refactory Polymyositis & Dermatomyositis:20 Adult Patients
Am J Med 91:162-168, Cherin,P.,et al, 1991
Clinical Uses of Intravenous Immunoglobulins
Ann Int Med 112:278-292, Berkman,S.A.,et al, 1990
Prednisone Use in Concurrent Autoimmune Diseases
Arch Neurol 36:103-106, Harati,Y.,et al, 1979
Cranial Neuropathy, Myeloradiculopathy, & Myositis, Complications of Mycoplasma Pneumoniae Infection
Arch Neurol 36:476-477, Rothstein,T.L.,et al, 1979
HLA-B8 in Polymyositis
NEJM 298:1260, Behan,W.M.H.,et al, 1978
Eosinophilic Polymyositis
Ann Neurol 1:65, Layzer,R.B.,et al, 1977
Cause of Weakness in Myasthenia Gravis
NEJM 294:722, Grob,D., 1976
Adult Toxoplasmosis Presenting as Polymyositis & Cerebellar Ataxia
Ann Int Med 82:367, Greenlee,J.,et al, 1975
Dysphagia and a rash
BMJ 361:k1590, McFarlane, M. & Disney, B., 2018
Mechanisms, Causes, and Effects of Hypercapnia
UptoDate Dec, Feller-Kopman, D.J. & Schwartzstein, R.M., 2016
Cancer-Associated Myositis and Anti-p155 Autoantibody in a Series of 85 Patients with Idiopathic Inflammatory Myopathy
Medicine 89:47-52, Trallero-Araguas,E.,et al, 2010
Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008
Polymyositis
Neurol 61:316-321, van der Meulen,M.F.G.,et al, 2003
Neurologic Aspects of Inflammatory Bowel Disease
Neurol 45:416-421, Lossos,A.,et al, 1995
Polymyositis, Dermatomyositis, and Inclusion-Body Myositis
NEJM 325:1487-1498, Dalakas,M.C., 1991
Severe Polymyositis-Like Syndrome Associated with Zidovudine Therapy of AIDS & ARC
NEJM 318:708, Bessen,L.J.,et al, 1988
The Frequency of Malignant Neoplasms in Patients with Polymyositis-Dermatomyositis, A Controlled Study
Arch Int Med 145:1835-1839, Manchul,L.A.,et al, 1985
Penicillamine-Induced Myositis
Am J Med 77:719-722, Halla,J.T.,et al, 1984
Phenytoin Hypersensitivity:38 Cases
Neurol 29:1480-1485, Harunda,F., 1979
Neurologic Manifestations of Progressive Systemic Sclerosis, 1972
Nebraska Med J 58:106, Aita,J.A., 1973